Page 3 - Ladyn News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ladyn. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ladyn Today - Breaking & Trending Today

Dyne Therapeutics, Inc. (NASDAQ:DYN) Major Shareholder Venture Fund Xi L.P. Atlas Sells 184,501 Shares

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) major shareholder Venture Fund Xi L.P. Atlas sold 184,501 shares of the firm’s stock in a transaction that occurred on Wednesday, February 21st. The shares were sold at an average price of $22.57, for a total value of $4,164,187.57. Following the transaction, the insider now directly owns […] ....

United States , Raymond James , Frazier Life Sciences Management , Venture Fund Xilp Atlas , Blackrock Inc , Dyne Therapeutics Inc , Vr Adviser , Dyne Therapeutics , Get Free Report , Street Corp , Dyne Therapeutics Daily , Nasdaq Dyn , Insider Trading , Nsider Trades ,

Jason P. Rhodes Sells 177,906 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN) Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) Director Jason P. Rhodes sold 177,906 shares of the company’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $23.89, for a total transaction of $4,250,174.34. Following the completion of the transaction, the director now owns 7,148,211 shares in […] ....

United States , Jasonp Rhodes , Raymond James , Blackrock Inc , Vr Adviser , Dyne Therapeutics Inc , Dyne Therapeutics Company Profile , Goldman Sachs Group Inc , Dyne Therapeutics , Get Free Report , Director Jason , Therapeutics Stock Down , Track Capital , Goldman Sachs Group , Sachs Group , Dyne Therapeutics Daily , Nasdaq Dyn , Insider Trading , Nsider Trades ,

Barclays PLC Acquires 17,603 Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN)

Barclays PLC grew its holdings in shares of Dyne Therapeutics, Inc. (NASDAQ:DYN – Free Report) by 21.5% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 99,574 shares of the company’s stock after purchasing an additional 17,603 shares during the quarter. Barclays PLC’s holdings […] ....

United States , Wildon Farwell , Raymond James , Barclays Plc , Dyne Therapeutics Inc , Securities Exchange Commission , Charles Schwab Investment Management Inc , Metlife Investment Management , Dimensional Fund Advisors , Venture Fund Xilp Atlas , Swiss National Bank , Dyne Therapeutics , Free Report , National Bank , Life Investment Management , Fund Advisors , Schwab Investment Management , Exchange Commission , Visit Holdingschannel , Dyne Therapeutics Daily , Nasdaq Dyn , Sec Filings , Hedge Fund Holdings , Institutional Investor Holdings ,

Dyne Therapeutics, Inc. (NASDAQ:DYN) Director Sells $3,851,926.08 in Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) Director Jason P. Rhodes sold 169,539 shares of the business’s stock in a transaction that occurred on Tuesday, February 20th. The shares were sold at an average price of $22.72, for a total transaction of $3,851,926.08. Following the transaction, the director now owns 6,815,965 shares of the […] ....

United States , Raymond James , Jasonp Rhodes , Vr Adviser , Blackrock Inc , Frazier Life Sciences Management , Securities Exchange Commission , Dyne Therapeutics Inc , Dyne Therapeutics , Get Free Report , Director Jason , Exchange Commission , Therapeutics Trading Down , Street Corp , Dyne Therapeutics Daily , Nasdaq Dyn , Insider Trading , Nsider Trades ,

Dyne Therapeutics, Inc. (NASDAQ:DYN) Insider Wildon Farwell Sells 5,493 Shares

Dyne Therapeutics, Inc. (NASDAQ:DYN – Get Free Report) insider Wildon Farwell sold 5,493 shares of the business’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $25.07, for a total transaction of $137,709.51. Following the sale, the insider now directly owns 163,503 shares in the company, valued […] ....

United States , Raymond James , Wildon Farwell , Rafferty Asset Management , Dyne Therapeutics Inc , Northern Trust Corp , Schroder Investment Management Group , Putnam Investments , American International Group Inc , Securities Exchange Commission , Dyne Therapeutics , Get Free Report , Exchange Commission , Investment Management Group , Trust Corp , International Group , Asset Management , Dyne Therapeutics Daily , Nasdaq Dyn , Insider Trading , Nsider Trades ,